The project EpiCure is currently undertaking the transition from basic research at LMU Munich to industry and will be incorporated soon.
At EpiCure, we are dedicated to developing groundbreaking cancer therapeutics. Our flagship product, Carbacitabin, is poised to revolutionize leukemia treatment and is already internationally patented. We aim to expand Carbacitabin's indications while actively exploring additional nucleic acid-based therapeutics. Our mission is to provide cancer patients, especially those with leukemia, with a low side-effect yet highly effective treatment. Join us on our journey to reshape the landscape of cancer therapy. #EpiCure #CancerTreatment #Innovation #leukemia
Company Details
- Employees
- 2
- Address
- Munich, Bavaria 81377, De
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- HQ
- Munich, Bavaria
Epicure Questions
Epicure's LinkedIn profile is https://de.linkedin.com/company/epicure-pharma
Epicure has
2 employees.
View email and phone details for 2
employees at Epicure.
Epicure's industry is
Pharmaceutical Manufacturing
Epicure's top competitors are
Quantilight,
Manex Ai,
Loyalift,
Blueprint Biomed,
Qualiwise,
Planet A Foods,
Science4life E.v.,
Biom Biotech Cluster Development Gmbh,
Roundpeg,
Phos4nova B.v..
Epicure's categories are Pharmaceutical Manufacturing
